Patents Examined by Michael Barker
  • Patent number: 11110146
    Abstract: The invention provides therapeutic compositions containing ground seed of Aframomum meleguata or an extract thereof, and methods for using such compositions to reduce platelet aggregation and treat medical disorders in a patient, such as cardiovascular disease.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: September 7, 2021
    Assignee: Paradise Health, Inc.
    Inventors: Curt Hendrix, Jack Joseph Kleid
  • Patent number: 11110145
    Abstract: Disclosed is to provide a composition which is derived from a natural product and exhibits an excellent effect of protecting cells from oxidative stress and a method for preparing the same. The extract and composition according to one aspect of the present disclosure are derived from a natural product, thus are safe. It can prevent, ameliorate and treat oxidative stress and neuron damage. Therefore, it allows to improve the quality of life of the elderly population without concerns about side effects and promote development of the related industry.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: September 7, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Hyungsu Kim, Ayoung Kim, Juewon Kim, Si Young Cho, Yong-Deog Hong
  • Patent number: 11110139
    Abstract: The disclosure provides an application of an anthocyanin extract in preparing a pharmaceutical composition for preventing and treating cardiac toxicity induced by Anthracyclines and the pharmaceutical composition, wherein the pharmaceutical composition comprises an effective dose of the anthocyanin extract; and the anthocyanin extract refers to an extract obtained from mature fruits of a zygophyllaceous nitraria plant and having a total anthocyanin content greater than 700 mg CGE/g and a total antioxidant capacity greater than 200 mg TE/g. Cytobiology and molecular biology studies prove that the anthocyanin extract has obvious protection effect to cardiomyocyte toxicity damage induced by anthracyclines and may be used for preventing and alleviating cardiotoxicity of an antharcyclines anticancer drug, thereby expanding a clinical application of the antharcyclines anticancer drug and relieving toxic and side effects brought by the antharcyclines anticancer drug to a patient and pain of a chemotherapy patient.
    Type: Grant
    Filed: December 5, 2017
    Date of Patent: September 7, 2021
    Assignee: Northwest Institute of Plateau Biology, Chinese Academy of Sciences
    Inventors: Tingting Gao, Hongtao Bi, Lixin Wei, Yuzhi Du, Hongxia Yang, Cen Li
  • Patent number: 11102982
    Abstract: The present invention relates to the fields of malaria and dengue virus. More specifically, the present invention provides compositions and methods useful for the treatment and prevention of malaria and dengue virus. In particular embodiments, a composition comprises mosquito nectar feed and Chromobacterium sp_Panamam (Csp_P).
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: August 31, 2021
    Assignee: The Johns Hopkins University
    Inventors: George Dimopoulos, Sarah M. Short, Jose L. Ramirez
  • Patent number: 11103545
    Abstract: The present invention relates to a composition a maximum of six, in particular a maximum of five or four different plant extracts for use in the prevention and/or treatment of diabetes type II or type 1. At least one plant extract has antioxidative properties and/or antioxidant enzyme inducing properties; at least one plant extract has anti-inflammatory properties; at least one plant extract has immune modulating properties; and at least one plant extract has neuronal hormone modulating properties.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: August 31, 2021
    Inventor: Shanta Banerjee
  • Patent number: 11103546
    Abstract: A composition having a mixture of several different edible oils and methods of use of thereof for alleviating discomfort associated with oral complications and/or providing nutrition by administering such composition are disclosed.
    Type: Grant
    Filed: January 29, 2015
    Date of Patent: August 31, 2021
    Assignee: VITA ICE THERAPEUTICS LLC
    Inventors: Mark Margulies, Dennis L. Zak
  • Patent number: 11098382
    Abstract: The present invention relates to a agave syrup product having a low water content. The agave syrup product retains the physical and palatable properties of untreated agave syrup while having a prolonged shelf-life. It can be advantageously used to sweeten beverages (such as hot beverages) and in the manufacture of pharmaceutical compositions (such as throat lozenges) and/or confectionary.
    Type: Grant
    Filed: November 7, 2018
    Date of Patent: August 24, 2021
    Assignee: IAF SCIENCE HOLDINGS LTD.
    Inventor: John Lawrence Rowe
  • Patent number: 11083757
    Abstract: A cognitive decline inhibitor or a learning ability improver is provided, which comprises, as an active ingredient, a liver hydrolysate having a lipid content of less than 2 mass % or a phosphatidylcholine content of less than 1 mass %.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: August 10, 2021
    Assignee: ZERIA PHARMACEUTICAL CO., LTD.
    Inventors: Kotaro Yamada, Hidetomo Sakurai, Osamu Nakagawasai, Koichi Tanno
  • Patent number: 11083762
    Abstract: The present disclosure provides a method for treating and/or alleviating nervous diseases, including: administering an effective amount of a water extract of a plant of Gracilariaceae or a ferment thereof to a subject in need thereof to treat and/or alleviate a nervous disease thereof, wherein the ferment of the water extract of a plant of Gracilariaceae is a lactic acid bacteria ferment.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: August 10, 2021
    Assignee: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: I-Hong Pan, Wei-Hsuan Hsu, Chu-Hsun Lu, Shu-Fang Wen, Hsin-Chieh Wu
  • Patent number: 11083767
    Abstract: Provided is a composition for preventing, improving or treating obesity, which includes a Platycodon grandiflorum extract as an active ingredient and a method for preparing the extract with an improved anti-obesity effect. The extract shows an effect of inhibiting increases in body weight and fat mass caused by a high-fat diet for normalization, an increase in fasting blood glucose and a decrease in energy expenditure in a diet-induced obesity mouse model. Further, compared to an extract prepared by a conventional extraction method, the Platycodon grandiflorum extract shows a more excellent effect of inhibiting increases in body weight and fat mass, fasting blood glucose, and blood lipid and adipokine contents in experiments, resulting in an excellent anti-obesity effect. Therefore, the Platycodon grandiflorum extract prepared is expected to be useful for preventing obesity and treating obesity-related complications that can be caused by an increase in fat mass as well as obesity.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: August 10, 2021
    Assignee: KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Myung-Sook Choi, Eun-Young Kwon, Ye Jin Kim, Ri Ryu
  • Patent number: 11083764
    Abstract: A pharmaceutical composition containing dry powder of pine (Pinus) needles and dry peels and pits of grapes extract and pharmaceutically acceptable additive, dry extracts of ginger (Zingiber officinale), green tea (Camellia sinensis), yellow ginger (Curcuma longa), yellow mustard (Brassica hirta) seeds, white pepper, pomegranate (Punica granatum) bark and dry powder of pomegranate (Punica granatum) juice.
    Type: Grant
    Filed: September 21, 2020
    Date of Patent: August 10, 2021
    Inventor: Babry Oren
  • Patent number: 11077165
    Abstract: The invention provides (1) methods for modulating gene expression in senescent mammals by administering antioxidant-comprising compositions to the mammals and (2) antioxidant-comprising compositions that modulate gene expression and/or reduce the oxidative stress of such mammals.
    Type: Grant
    Filed: November 9, 2005
    Date of Patent: August 3, 2021
    Assignee: Hills Pet Nutrition, Inc.
    Inventors: Steven Curtis Zicker, Inke Paetau-Robinson, Karen Joy Wedekind
  • Patent number: 11071762
    Abstract: Use of an olive oil milling by-product (Alperujo or Olive Pomace) for the co-processing and co-extraction of natural compounds from medicinal and aromatic plants, fruits and agricultural waste, algae and other microorganisms. Separation and stabilization of fractions containing either hydrophilic or liposoluble compounds. The plants may include Cannabis.
    Type: Grant
    Filed: January 4, 2018
    Date of Patent: July 27, 2021
    Assignee: Oliphenol, LLC
    Inventor: Roberto Crea
  • Patent number: 11065281
    Abstract: The present invention relates to a composition for preventing or treating ischemic enteritis containing a DNA fragment mixture isolated from sperm or testis of fish. The composition of the present invention was verified to have excellent effects in the prevention or treatment of ischemic enteritis. In addition, the composition for preventing or treating ischemic enteritis of the present invention was verified to be safe and have few side effects even when administered for a long period of time. Therefore, a medicine for ischemic enteritis, which is safe without side effects and has an excellent treatment effect, is developed by using the composition for preventing or treating ischemic enteritis of the present invention, and thus the composition of the present invention is expected to be a great help in the treatment of ischemic enteritis.
    Type: Grant
    Filed: May 25, 2016
    Date of Patent: July 20, 2021
    Assignee: PharmaResearch Co., Ltd.
    Inventors: Ik Soo Kim, Seung Gul Baek, Chang Ju Kim, Jung Won Jeon
  • Patent number: 11058735
    Abstract: The invention relates, in general, to healing formulations containing pomegranate seed oil, rosa canina fruit oil, and inula viscosa oleoresin or extract. In some instances the formulations may also contain citrus medica vulgaris etrog oil or extract and other ingredients. The healing formulations are all natural, do not include any artificial preservatives and are safe and effective for treating certain skin disorders and conditions.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: July 13, 2021
    Assignee: POMEGA, INC
    Inventors: Tzeira Sofer, Tamara Meyer
  • Patent number: 11058666
    Abstract: Methods and compositions are provided for alleviating and/or preventing one or more side effects associated with exposure to radiation in a subject exposed to radiation or at risk for exposure to radiation comprising oral administration to the subject of an amount of an edible source of melanin effective to alleviate a side effect associated with radiation.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: July 13, 2021
    Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE
    Inventors: Ekaterina Dadachova, Arturo Casadevall
  • Patent number: 11045503
    Abstract: The invention relates to a pharmaceutical composition consisting of snail slime Helix aspersa muller (Cryptomphalus aspersus) (20% to 50%), camomile extract (1-4%), propolis 1l-4%), and pharmaceutically acceptable excipients and/or additives for forming a formulation of low, intermediate or high viscosity (10 to 1000 Pa-s). Said composition is in the form of a lotion, soap, cream or gel, which is embedded in a gauze-type fabric in the form of a plaster that can be applied to lesions caused by the different types of rosacea. The composition can also contain natural extracts such as marigold extract, honey and vegetable oils. The invention also relates to the method for producing the composition and to the use thereof for preparing a medicament or device for preventing, treating or curing lesions caused by rosacea, on the skin of the face or the body.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: June 29, 2021
    Assignee: MUCIDERM S.A.
    Inventor: Elmo Moreno Gonzalez
  • Patent number: 11033598
    Abstract: A method for preventing or treating hearing loss includes administering a composition comprising an oat extract to a subject. The method may use avenanthramide or a derivative thereof an oat extract. The oat extract has an effect on hair cells of the cochlea, spinal ganglion cells, and angiocytes, and an effect of inhibiting occurrence of hearing loss and can be usefully used for preventing or treating hearing loss. In particular, since the oat extract is a natural product and has stability without cytotoxicity, the composition containing the oat extract as an active ingredient has a safety advantage for long-term use without side effects on the human body.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: June 15, 2021
    Assignees: INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY, CHONNAM NATIONAL UNIVERSITY HOSPITAL, REPUBLIC OF KOREA (MANAGEMENT : RURAL DEVELOPMENT ADMINISTRATION)
    Inventors: Hyong Ho Cho, Hyung Seok Kim, Sung Su Lee, Yu Young Lee
  • Patent number: 11033487
    Abstract: A method for reducing the appearance of a skin pore in skin of a subject in need thereof is disclosed. The method can include topically applying to the skin pore a composition comprising effective amount of Albizia julibrissin bark extract, and hydrolyzed soy flour, wherein topical application of the composition reduces the appearance of the size of the skin pore.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: June 15, 2021
    Assignee: Mary Kay Inc.
    Inventors: David Gan, Geetha Kalahasti, Lisha Van Pelt
  • Patent number: 11033533
    Abstract: In one aspect, the invention relates to a compound of the structure: or a pharmaceutically acceptable salt thereof, and a crystalline form of this compound, having neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising this compound; methods of using this compound; and processes for preparing this compound.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: June 15, 2021
    Assignee: THERAVANCE BIOPHARMA R&D IP, LLC
    Inventors: Melissa Fleury, Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta